From the Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC.
the Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC.
J Pediatr Gastroenterol Nutr. 2023 Dec 1;77(6):753-759. doi: 10.1097/MPG.0000000000003941. Epub 2023 Sep 12.
Feeding tubes can provide a temporary or long-term solution for nutritional therapy. Little is known regarding the use of feeding tubes in patients with eosinophilic esophagitis (EoE). We sought to describe the characteristics and outcomes in EoE patients requiring tube feeding.
This was a retrospective cohort study of EoE patients at a large tertiary care health system. Demographics, clinical characteristics, and endoscopic findings were extracted from medical records, and patients who had a feeding tube were identified. Patients with and without a feeding tube were compared. Details about the tube, complications, and treatment were extracted. Growth, global symptomatic, endoscopic, and histopathologic (<15 eos/hpf) responses were compared before and after the initiation of feeding tube therapy.
We identified 39 of 1216 EoE patients who had a feeding tube (3%). Feeding tube patients were younger (mean age 6.3 years), reported more vomiting, and had a lower total endoscopic reference score than non-feeding tube patients ( P < 0.01 for all). Tubes were used for therapy for an average of 6.8 years, with most patients (95%) receiving both pharmacologic and formula treatment for EoE. An emergency department visit for a tube complication was required in 26%. Tube feeding improved body mass index z score ( P < 0.01), symptomatic response (42%), endoscopic response (53%), and histologic response (71%).
Among EoE patients, only a small subset required a feeding tube and predominantly were young children with failure to thrive. Feeding tubes significantly improved growth and, when used in combination with other treatments, led to reduced esophageal eosinophilic inflammation.
饲管可为营养治疗提供临时或长期解决方案。对于嗜酸性食管炎(EoE)患者使用饲管的情况知之甚少。我们旨在描述需要进行饲管喂养的 EoE 患者的特征和结局。
这是一项针对大型三级保健系统中 EoE 患者的回顾性队列研究。从病历中提取人口统计学、临床特征和内镜检查结果,并确定有饲管的患者。比较有和没有饲管的患者。提取有关饲管、并发症和治疗的详细信息。比较饲管治疗开始前后的生长、总体症状、内镜和组织病理学(<15 个 eos/hpf)反应。
我们在 1216 名 EoE 患者中发现了 39 名(3%)有饲管。饲管患者年龄较小(平均年龄 6.3 岁),报告呕吐更多,总内镜参考评分低于无饲管患者(所有 P<0.01)。饲管平均用于治疗 6.8 年,大多数患者(95%)接受 EoE 的药物和配方治疗。需要因饲管并发症前往急诊的患者有 26%。饲管喂养改善了体重指数 z 评分(P<0.01)、症状反应(42%)、内镜反应(53%)和组织学反应(71%)。
在 EoE 患者中,只有一小部分需要饲管,主要是生长不良的幼儿。饲管显著改善了生长,并且当与其他治疗方法联合使用时,可减少食管嗜酸性粒细胞炎症。